IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
100.15%
Total 13F principal
$102,938,901
Principal change
-$162,415,252
Total reported market value
$103,141,953
Number of holders
21
Value change
-$172,928,867
Number of buys
3
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q3 2019

As of 30 Sep 2019, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $102,938,901 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, HBK INVESTMENTS L P, Linden Advisors LP, PALISADE CAPITAL MANAGEMENT LLC/NJ, JPMORGAN CHASE & CO, SSI INVESTMENT MANAGEMENT LLC, FMR LLC, and CSS LLC/IL. This page lists 21 institutional bondholders reporting positions for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.